4 illness stages:
-
early prodromal phase:
sub-clinical and non-specific symptoms, attenuated mania symptoms
-
late prodromal phase:
bipolar disorder NOS
-
subsyndromal stage:
cyclothymia, hypomania
-
syndromal stage:
bipolar disorder-I and II
3 approaches:
clinical: (e.g. attenuated symptoms, ADHD, ODD, depression etc.)
endophenotypic
genetic (including familial risk and genotype)
|
3 illness stages:
-
putative risk factors:
first-degree relative with bipolar disorder, sexual/physical abuse, psychosocial stress, substance use/abuse, stimulant/antidepressant medication exposure, n-3 fatty acid deficiency
-
prodromal clinical features:
ADHD, unipolar depression, hypomania, anger/irritability, anxiety
mania/bipolar-I disorder onset
|
3 risk groups:
-
sub-threshold mania group
presence of an A criterion plus at least two B criteria, duration of 2–4 days
-
depression plus cyclothymic features group
depression: depressed mood or loss of interest plus 2 depression criteria, duration ≥1 week cyclothymic features: numerous episodes with sub-threshold mania as in group I and depression, duration of sub-threshold mania 4hrs/day for ≥4 cumulative days lifetime
-
depression plus genetic risk group
depression as in group II and first-degree relative with bipolar disorder
|
5 marker domains:
family history
-
‘prodromal symptom complex’
including symptoms of mania, comorbid ADHD and/or ODD, and temperamental features
neurobiological markers
endophenotypic marker
temperamental features
|
3 risk stages:
-
risk state
specific changes in sleep and circadian rhythm plus ≥1 other secondary risk factor
-
high risk state
one primary plus ≥1 secondary risk factor
ultra-high risk state >1 primary risk factor
Primary risk factors:
Secondary risk factors:
changes in sleep
impairment in psychosocial functioning
symptoms or diagnosis of ADHD
substance use/abuse
anxiety
current or past mood disorder other than bipolar disorder
|
3 risk clusters:
genetic risk
-
environmental risk
childhood trauma, sexual/physical abuse, neglect or parental loss
profile of risk biomarkers
|